Home » Topics » Regulatory » Patents

Patents
RSS

Teon Therapeutics patents new adenosine A2A receptor antagonists

Feb. 10, 2021

GenScript discloses new anti-CD47/anti-PD-1 bispecific antibodies

Feb. 9, 2021

King Abdulaziz University describes DPP-IV inhibitors

Feb. 9, 2021

GB005 identifies new BTK inhibitors

Feb. 9, 2021

Canopy Growth synthesizes cannabinoid CB1 and CB2 receptor ligands

Feb. 9, 2021

ORIC Pharmaceuticals presents new CD73 inhibitors

Feb. 9, 2021

Good T Cells patents molecules for treating immune checkpoint inhibitor-resistant cancer

Feb. 8, 2021

Scenic Immunology synthesizes new QC and/or QPCTL inhibitors

Feb. 8, 2021

Pfizer presents new TLR agonists

Feb. 8, 2021

Kymera Therapeutics patents CRBN inhibitors

Feb. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...